These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31107862)

  • 41. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease.
    Cameron SA; Carr M; Pahl E; DeMarais N; Shulman ST; Rowley AH
    Arch Dis Child; 2019 May; 104(5):451-455. PubMed ID: 30413485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
    JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
    Yamashita M; Ae R; Yashiro M; Aoyama Y; Sano T; Makino N; Nakamura Y
    Pediatr Cardiol; 2017 Feb; 38(2):375-380. PubMed ID: 27878631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five years of Kawasaki disease in the Netherlands: a national surveillance study.
    Tacke CE; Breunis WB; Pereira RR; Breur JM; Kuipers IM; Kuijpers TW
    Pediatr Infect Dis J; 2014 Aug; 33(8):793-7. PubMed ID: 24463809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
    Liang YC; Chang CH; Lin MT; Kao FY; Huang SK; Wu MH
    Pediatr Res; 2020 Apr; 87(5):961-966. PubMed ID: 31711068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
    Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
    Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous immunoglobulin for the treatment of Kawasaki disease.
    Broderick C; Kobayashi S; Suto M; Ito S; Kobayashi T
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014884. PubMed ID: 36695415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country.
    Mat Bah MN; Alias EY; Razak H; Sapian MH; Foo FH; Abdullah N
    Eur J Pediatr; 2021 Aug; 180(8):2599-2606. PubMed ID: 34086103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kawasaki's disease in northern Italy: a multicenter retrospective study of 250 patients.
    Falcini F; Cimaz R; Calabri GB; Picco P; Martini G; Marazzi MG; Simonini G; Zulian F
    Clin Exp Rheumatol; 2002; 20(3):421-6. PubMed ID: 12102484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].
    Wang X; Pan SL; DU ZH; Ji ZX; Luo G; Sun HX; Ma SJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Apr; 24(4):399-404. PubMed ID: 35527415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of coronary artery lesions in children in Kawasaki syndrome.
    Maccora I; Calabri GB; Favilli S; Brambilla A; Trapani S; Marrani E; Simonini G
    Eur J Pediatr; 2021 Jan; 180(1):271-275. PubMed ID: 32556506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
    EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
    Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Kuwabara M; Makino N; Matsubara Y; Matsubara D; Kosami K; Sasahara T; Belay ED
    Am Heart J; 2020 Jul; 225():120-128. PubMed ID: 32497905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unexpectedly high incidence of Kawasaki Disease in a Canadian Atlantic Province- an 11-year retrospective descriptive study.
    Alkanhal A; Saunders J; Altammar F; Huber AM; Lynk A; MacLeod A; Ortiz-Alvarez O; Adams M; Ramsey S; Stringer E; Warren A; Lang B
    Pediatr Rheumatol Online J; 2023 Apr; 21(1):30. PubMed ID: 37013572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.